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Abstract The objective of this study was to determine the 
transcellular metabolism of leukotriene & by rabbit blood 
cells. Mixed peripheral blood leukocyte preparations wi th and 
without platelets in a ratio of 1:40 were challenged with the 
Ca2+-ionophore A23187. 5-Lipoxygenase metabolites produc- 
tion was assessed by RP-HPLC coupled with diode-array UV 
detection. In light of the observation that leukotriene C, pro- 
duction in leukocyte-platelet coincubation was the same as 
with leukocytes alone, mixed coincubation of human and rab- 
bit blood cells was tested. Rabbit leukocytes with human plate- 
lets resulted in a significant increase of leukotriene C4 produc- 
tion, while no changes were observed in human leukocytes 
with or without rabbit platelets. In agreement with these re- 
sults, intact rabbit platelets or rabbit platelet lysates, unlike 
human platelets, were not able to convert synthetic leuko- 
triene 1\4 free acid to leukotriene C , . I  These data provide 
evidence that rabbit leukocytes are able to make a significant 
amount of leukotriene & available for transcellular metabo- 
lism, while rabbit platelets, unlike human platelets, lack leuko- 
triene C,-synthase activity.-Sala, A, T. Testa, F. Nobili, and 
G. Folco. Transcellular metabolism of leukotriene & by rabbit 
blood cells: lack of relevant LTC,-synthase activity in rabbit 
platelets. J. Lipid Res. 1997. 38: 627-633. 
Supplementary key words human platelets rabbit leukocytes 
Leukotrienes (LT), e.g., leukotriene B4 (LTB,) and 
leukotriene C4 (LTC,), are products of the 5-lipoxyge- 
nase (5-LO; EC 1.13.1 1.34) pathway of arachidonic acid 
(AA) metabolism and are potent biologically active au- 
tacoids. They are involved in microvascular inflamma- 
tory responses, where LTC4 and LTD4 are able to affect 
vascular permeability, causing plasma extravasation, 
and LTB4 has specific effects on the adhesion of neutro- 
phils to endothelial cells and extravasation of white cells 
( 1 ) .  The generation of LT exhibits remarkable cellular 
specificity; polymorphonuclear leukocytes (PMNL) 
generate predominantly the dihydroxyderivative LTB4, 
with only minor amounts of LTC4, whereas mast 
cells and eosinophils show preferential generation of 
cysteinyl-leukotrienes (cys-LT) (2). Recently another 
process of biosynthesis of cys-LT has been described, 
where the unstable metabolic intermediate LT& is fur- 
ther metabolized by vicinal cells (possessing the LTC4- 
synthase but not the 5-lipoxygenase enzyme) into leuko- 
triene C4. Such a reaction involves the cooperation of 
PMNL with platelets, endothelial cells, and smooth 
muscle cells (3-5). This process has been termed 
“transcellular biosynthesis” and suggests that the cellu- 
lar environment (i.e., cell-cell interaction) exerts an 
important control on the production of eicosanoids 
(6). 
Recent studies on transcellular metabolism in com- 
plex organ systems (7-10) showed that perfusion and 
activation of PMNL in isolated lung or heart of the rab- 
bit resulted in the production of significantly increased 
amounts of cysteinyl leukotrienes, compared to activa- 
tion of PMNL alone. These biochemical changes were 
associated with significant functional and morphologi- 
cal changes, suggesting that transcellular biosynthesis 
of cysteinyl leukotrienes might indeed be of physiopath- 
ological relevance. The results are of interest with re- 
spect to the potential of rabbit blood cells in the trans- 
fer and metabolism of leukotriene &. 
We have studied the transcellular metabolism of leu- 
kotriene A, using rabbit mixed leukocyte preparations 
and coincubations of leukocytes and platelets. The abil- 
Abbreviations: LTA,, Ieukotriene A,; LTB,, leukotriene B,; LTC,, 
leukotriene Cq; PMNL, polymorphonuclear leukocytes; 5-L0, 5-li- 
poxygenase; PBS’, phosphate-buffered saline without Ca4+ and Mg’+; 
PRP, platelet-rich plasma; 5,12diHETE, 5(S),l?(S)-dihydroxy-6,10- 
~rans-8,14ciseicosatetraenoic acid; CDNB, l-chloro-?,4dinitroben- 
zene; RP-HPLC, reverse phase high performance liquid chromatogra- 
phy; AA, arachidonic acid. 
‘To whom correspondence should be addressed. 
*Present address: Bassini Hospital, Via M. Gorki 50,20092 Cinisello 
B., Milan, Italy. 
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ity of rabbit leukocytes tci transfer leukotricne A, atitl 
of rabbit platelets to synthesize L,T(:4, has been tested 
using heterologous coincubations with, respectively, hu- 
man platelets and leukocytes. 
The results showed that rabbit platelets do  not synthe- 
size LTC, when coincubated with leukocytes or when 
exposed to synthetic LTA, free acid. On the other hand, 
rabbit leukocytes are able to make significant amounts 
of intact LTA, available for transcellular metabolism. 
EXPERIMENTAL PROCEDURES 
Chemicals and reagents 
All chemicals used were reagent grade and obtained 
from commercial sources. Eicosanoids were purchased 
from Cayman Chemical Co. (Ann Arbor, MI). HPLC- 
grade solvents were obtained from Merck (Darmstadt, 
Germany). Type I "plus" water was obtained using a 
MilliQ Plus water purifier (Millipore, Molsheim, 
France) with double distilled water. 
Preparations of rabbit and human blood cells 
After centrifugation for 20 min at room temperature 
and 200 g, platelet-rich plasma (PRP) was removed, re- 
acidified with ACD (1 / 10 of the volume) and centri- 
fuged for 15 min at room temperature and 1000 g. Pel- 
leted platelets were resuspended with 5 ml of washing 
buffer (36 mM citric acid, 5 n i ~  glucose, 5 mM KCl, 2 
mM CaC12, 1 t n M  MgC1,45Hp0, 103 mM NaC1, pH 6.5) 
containing 0.4%, w/v, BSA and prostaglandin E ,  (final 
concentration 100 nM) . Platelets were further centri- 
fuged for 15 min at room temperature and 800 g and 
finally resuspended in phosphate-buffered saline with- 
out Cay' and M$' (PBS= ). 
Leukocytes were prepared from residual blood by 
dextran sedimentation and hypotonic lysis of contami- 
nating red cells. Mixed leukocytes were washed twice 
with PBS= and resuspended in PBS'. Viability (295%) 
was assessed by exclusion of Trypan Blue dye. 
Rabbit polymorphonuclear leukocytes were purified 
from mixed leukocytes by centrifugation on Ficoll cush- 
ions (d 1.077 g/ml) for 30 min at rooni temperature 
and 400 g. 
Human blood (40 ml) was drawn from healthy do- 
nors that had not taken any medications for at least l 
week; it was collected into a 50-ml polypropylene centri- 
fuge tube containing 5.7 ml of ACD and carefully 
mixed. After centrifugation for 15 min at room temper- 
ature and 280 g, platelet-rich plasma (PRP) was re- 
moved; platelets and mixed leukocytes were prepared 
as described for rabbit cells. 
Plntelets and leuhoci te5 weit. coitrited using 't rnotlr- 
lied Neuhnuer chnmbcr . 
Cell incubations 
Kabbit or human leukocytes (5 X IO6 cells nil ' )  and,'  
or homologous or heterologous platelets (2 X 10' cells 
ml-') were treated with Cay+ (2 mM) and Mg2+ (0.5 I I ~ M )  
and, after pre-incubation at 37°C for 5 min, the calcium 
ionophore A23187 (2 pin) (Calbiochetn, La.Jolla, C A )  
~7as added to trigger eicosanoid metabolism. 
Stimulation was terminated after 10 min with 2 vol of. 
ice-cold methanol containing the HPLC internal stan- 
dard PGB:, (25 ng), and samples were stored a t  -YO"( :  
until RP-HPLC analysis. 
Metabolism of synthetic LTA4 by intact platelets 
LTA free acid was obtained through basic hydrolysis 
of LTAl methyl esther (LTA,-ME). Briefly, LTA1-ME was 
reconstituted in ice-cold acetone-0.25 M NaOH 4: 1 (v/ 
v) and hydrolysis was performed at room temperature 
for 60 min. LTA., free acid was added to rabbit ( 10x-4 
X 10' cells) or human platelets (loq cells) containing 
BSA (0.5%, w/v)  within 1 h of hydrolysis, at different 
final concentrations (0.2-2 p ~ ) .  Purity of LTA,-ME was 
checked by normal phase HPLC, using cyclohexane- 
ethyl acetate-triethylamine 99:O.S: 1 (v /v)  to isocrati- 
cally elute a Lichrospher Si-100 column (4 X 250 inin, 
5 pm; Merck) at a flow rate of 1 ml/min. LTA I free acid 
was checked by reverse phase HPLC using acetonitrile- 
0.01 M borate buffer, pH IO, 40:60 (v /v)  to isocratically 
elute an Ultrasphere RP-18 column (4 X 250 mrn, 5 pm; 
Beckman Analytical, Palo Alto, CA) at a flow rate of' 1 
ml/min ( 1  1). 
LJV absorbance was monitored at 280 nm and full U V  
spectra (240-340 nm) were acquired at a scan rate of 
0.5 Hz, using a diode-array UV detector (Mod. 168, 
Beckman Analytical). Identities of LTA ,-ME and LTA I 
free acid were assigned based on retention time arid on- 
line LW ahsorbance specti-a. 
Metabolism of exogenous LTAl was allowed to pro- 
ceed for I O ,  20, 40, and 60 min at 37°C. 
Metabolism of synthetic LTA, by lysed platelet 
preparations 
Human or rabbit washed platelets were resuspended 
in lysis buffer (0.05 M phosphate buffer, pH 7.4, 0.1 M 
sodium chloride, 2 m M  EDTA, 0.1 units/ml aprotinine, 
1 g/ml pepstatin, 1 pg/ml leupeptin) at a concentra- 
tion of 1-3 X 10" tnl - I ,  and sonicated 4 X 15 s on ice, 
using a sonifier (power setting 5 ,  Mod. XL, Heat Sys- 
tems, Farmingdale, NY) equipped with a microtip. Dis- 
rupted platelets were used either without further ma- 
nipulation or centrifuged 20 min at 4°C and 10,000 g, 
and the supernatant was used for glutathione S-trans- 
ferase activity determination. Proteins were quantitated 
628 Journal of Lipid Research Volume 38, 1997 
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spectrophotometrically using Coomassie Protein Assay 
Reagent (Pierce, Rockford, IL) with bovine serum albu- 
min as standard. The equivalent of 10' platelets, from 
platelet lysates, was added to a reaction mixture (900 
p1) containing 5 mM glutathione, 0.1 M phosphate 
buffer, pH 7.0, 1 mM EDTA (12). After 2 min of equili- 
bration, LTA4 free acid was added at a final concentra- 
tion of 1 p~ and the reaction was allowed to proceed 
for 1 min. 
Incubations were terminated with 2 vol of ice-cold 
methanol containing the HPLC internal standard PGBB 
(25 ng) and samples were analyzed by RP-HPLC. 
w-HPLC analysis 
Samples from cell incubations were diluted with wa- 
ter to a final methanol concentration lower than 20% 
and extraction was quickly carried out using a solid 
phase cartridge (Supelclean LC-18, Supelco, Bellafonte, 
PA); the retained material was eluted with 90% aqueous 
MeOH. After evaporation, the dried extract was recon- 
stituted in HPLC mobile phase A, (see below) (600 pI) 
and injected into an HPLC gradient pump system 
(Mod. 126, Beckman Analytical) connected to a diode- 
array W detector (Mod. 168, Beckman Analytical). UV 
absorbance was monitored at 280 and 235 nm, and full 
UV spectra (210-340 nm) were acquired at a rate of 0.5 
Hz. An aliquot (600 pl) of samples from exogenous 
LTA4 experiments was analyzed without prior extrac- 
tion. 
A multilinear gradient from solvent A (methanol- 
acetonitrile-water-acetic acid 10: 10:80:0.02, (v/v/v), 
pH 5.5 with ammonium hydroxide) to solvent B (meth- 
anol-acetonitrile 50:50 (v/v) at a flow rate of 1 ml/ 
min, was used to elute a 4 X 250 mm column (RP-18 
endcapped Lichrospher, 5 pm, Merck). Solvent B was 
increased to 35% over 6 min, to 65% over 25 min, and 
to 100% over 3 min. This method allowed separation 
of LTB4 from 5(S), 12(S)-dihydroxy-8,14cis-6,10-trunc 
eicosatetraenoic acid (5,12-diHETE) as well as from A6- 
trans LTB4 isomers. 
Positive identification ofAA metabolites was obtained 
through UV spectral analysis of chromatographic peaks 
eluting at characteristic retention times. Retention 
times of standard compounds were: 20-OH-LTB4, 12.5 
min; LTC,, 15.4 min; PGB2, 17.5 min; A6-trunsLTB4, iso- 
mers, 19.3 and 19.7 min; LTB4, 20.5 min; 5,12-diHETE, 
20.9 min; and 5,6-diHETE isomers, 24.4 and 25 min. 
Quantitation was carried out only on positively identi- 
fied peaks, using their HPLC peak areas relative to that 
of PGBB at 280 nm, and calculated from the responses 
of standard compounds. 
Assay of glutathione Stransferase activity 
Glutathione Stransferase (E.C.2.5.1.18) activity in 
human and rabbit platelet cytosol (100-400 pg protein) 
was measured spectrophotometrically at 340 nm in a 
reaction system containing 1 mM glutathione, 1 mM 
CDNB, 5% ethanol, and 0.1 M sodium phosphate, pH 
6.5, at 25°C (13). The increase in absorbance at 340 nm 
was monitored for 3 min using a Jasco spectrophotome- 
ter (V-530, Tokyo, Japan). Results were expressed as 
nmol of CDNB-glutathione conjugate formed per mg 
of protein per minute, using a molar extinction coeffi- 
cient of 9600 (mol/l)-] cm-' at 340 nm. 
Data analysis 
sis of variance (ANOVA) and Student's t-test. 
the mean (SEM) of n observations. 
significant. 
Amounts of LTA, metabolites were analyzed by analy- 
Values were expressed as mean 5 standard error of 
A value of P < 0.05 was considered to be statistically 
RESULTS 
Challenge with the calcium ionophore A23187 (2 p ~ ,  
10 min) of peripheral rabbit mixed leukocyte prepara- 
tions resulted in the production of LTB4 (18.7 ? 2.1 
pmol/106cells, n = 5 ) ,  LTC4 (8.6 ? 0.8 pmol/106 cells, 
n = 5) and of non-enzymatic-LT& metabolites (namely 
A"-trunsLTB4 isomers + 5,6 dihydroxy eicosatetraenoic 
acids); consistent with published data (8, 14), (0- 
oxidized LTB, metabolites, such as 20-hydroxy-LTB4 
(15) were not detected (Fig. 1) .  Minor amounts of 5(S), 
12 (S) -dihydroxy-8,14&-6,10-tran~icosatetraenoic acid 
(5,12-diHETE), a metabolite arising from the sequen- 
tial action of 5- and 12-lipoxygenase on the arachidonic 
acid (AA) (16), were also detected, indicating the pres- 
ence of platelets as contaminant of the mixed leukocyte 
preparation (3.1 +- 1.6 platelets per leukocyte, n = 5). 
Addition of homologous platelets in a ratio of 40: 1 with 
the leukocytes caused a significant increase of 5,12- 
diHETE and of LTB4 while LTC, production did not 
change (Fig. 1 and Fig. 2). Similar results were obtained 
using purified polymorphonuclear leukocytes. Al- 
though LTB4 production was higher than in mixed leu- 
kocyte preparations (42.3 -t 7.8 and 45.4 ? 4.2 pmol/ 
lofi cells, PMNL alone and PMNL + platelets, respec- 
tively; n = 3 ) ,  only minimal amounts of LTC4 were de- 
tected either in PMNL alone or in PMNL + platelets 
coincubations (1.9 2 0.9 and 1.7 5 0.8 pmol/106 cells, 
respectively; n = 3). 
Challenge of peripheral human mixed leukocyte 
preparation with the calcium ionophore A23187 (2 p ~ ,  
10 min) resulted in the expected profile of LTA4- 
derived metabolites (15). 20-Hydroxy-LTB4 was the 
main product, with significant amounts of LTA4, LTC4, 
and non-enzymatic-LTA, metabolites. Presence of con- 
Sulu et al. Rabbit platelets and LTCI transcellular biosynthesis 629 
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Fig. 1. 1,T& metabolites synthesized by rabbit leukocytes and 
PMNLplatelet coincubations. W absorbance profilr at 280 nm from 
the RP-HPLC of rabbit leukocytes (5  X 10" cells ml- ' )  (panel A) and 
leukocyte-platelet coincubations (ratio 1 : 40) (panel B) after chal- 
lenge with the Ca"-ionophore A23187 (2 p ~ ,  10 min, 37°C). Arrows 
indicate the retention time of' synthetic standards. 1,s.: internal stan- 
dard (PGB,!). 
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Fig. 2. Production of LTB,, LTC,, and 5.12-diHETE by mixed rabbit 
leukocyte preparations. Mixed rabbit leukocytes were challenged with 
the calcium ionophore A23187 (2 p ~ ,  10 min, 37"C), with or without 
rabbit or hunian platelets in a ratio of 40: 1 with the leukocytes. Values 
are expressed as pmol/ lo6 cells. Means f SEM of 5-7 different prepa 
rations. 
LTB4 LTC4 5,12-diHETE 
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Fig. 3. Production of LTB,, LTC.,, and 5,lBdiHETE by mixed hu- 
man leukocyte preparations. Mixed human leukocytes were chal- 
lenged with the calcium ionophore A23187 (2 PM, 10 min. 37Y:). 
with or without human or rabbit platelets in a ratio of 40: 1 with the 
leukocytes. Values are expressed as pmol/lO" cells. Means t SEM of 
5 different preparations. 
taminating platelets (2.1 5 1.3 platelets per leukocyte, 
n = 5) was unmasked by minor amounts of 5,lZ-di- 
HETE. In agreement with previous data (4, 17), addi- 
tion of homologous platelets resulted in a significant 
increase of LTC,, together with the increase of 5,12-di- 
HETE (Fig. 3) .  
In light of the results obtained with rabbit leukocyte- 
platelet coincubations, mixed preparations of human 
and rabbit blood cells were tested. Addition of human 
platelets, in a ratio of 40:l with rabbit leukocytes, re- 
sulted in a 2-fold increase of LTC4, showing that rabbit 
leukocytes were able to transfer intact LTA, to platelets. 
On the other hand, addition of rabbit platelets to hu- 
man leukocytes resulted in a significant increase of 
LTB4, as observed with rabbit leukocytes, but no 
changes were observed for LTC4 (Figs. 2 and 3). 
Human platelets were able to efficiently convert exog- 
enous LTA, into LTC,, in agreement with published 
data (4, 18). Rabbit platelets, in spite of prolonged incu- 
bations with different concentrations of LTA.,, were not 
able to synthesize amounts of cysteinyl leukotrienes as 
detectabie by RP-HPLC (Fig. 4). 
Human platelet lysates synthesized significant 
amounts of LTC4 upon addition of 1 ~ L M  synthetic L=T& 
(1 14.3 5 8.8 pmol/ 10" platelet equivalent). Disrupted 
rabbit platelets did not synthesize detectable amounts 
of LTC, (Fig. 5 ) .  
Glutathione S-transferase activity was 26.6 t 9 (n = 
9) nmol min ' per mg of protein in human platelet ly- 
sates, and 9.3 2 3 (n = 4) nmol min-' per mg of protein 
in rabbit platelet lysates (19). 
630 Journal of Lipid Research Volume 38, 1997 
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Fig. 4. Production of LTC, by human or rabbit platelets incubated 
with increasing concentrations of synthetic LTA+ Human or rabbit 
platelets (10” cells) were incubated with increasing concentrations of 
synthetic LTA, free acid (0.2-2 PM, 10 min, 37°C) in presence of BSA 
(0.5%). Values are expressed as pmol. Means ? SEM of 3 different 
platelet preparations 
DISCUSSION 
The importance of cell-cell interactions and cooper- 
ation for the production of biologically active leuko- 
trienes requires the elucidation of the potential for 
transcellular metabolism of blood cells from the species 
most widely used in pharmacological research. The re- 
sults reported in this study clearly show that rabbit leu- 
kocytes are able to export significant amounts of the 
unstable intermediate LT&, and therefore can partici- 
pate as “donor cells” to transcellular biosynthetic pro- 
cesses involving “acceptor cells” other than platelets. 
Evidence of the cooperation of rabbit polymorphonu- 
clear leukocyte with pulmonary endothelial cells for the 
production of cysteinyl leukotrienes has been presented 
by Grimminger et al. (7). 
A recent report by Palmentier et al. (20), as well as 
data obtained in our laboratory (21, 22), suggest that 
intact LTA, might represent the main LTA4-metabolite 
released by human or bovine PMNL. This important o b  
servation further enhances the potential for transcellu- 
lar metabolism of LTA4 as the main biosynthetic path- 
way for cysteinyl leukotriene biosynthesis in the 
presence of a targeted stimulus of polymorphonuclear 
leukocytes. 
Although a very early report hypothesized that rabbit 
platelets were able to synthesize a slow reacting sub- 
stance of anaphylaxis (SRSA) from arachidonic acid 
(23), we did not not find any LTC, or 5-HETE after 
challenge of rabbit platelets with the calcium iono- 
phore A23187, in agreement with a recent report pro- 
viding the profile of arachidonic acid metabolites in 
rabbit platelets as analyzed by gas chromatography- 
mass spectrometry (24). 
0 10 20 
Retention Time (min) 
0 
Fig. 5. LTA, metabolites synthesized by human and rabbit platelet 
lysates upon addition of synthetic LTA, free acid. UV absorbance pro- 
file at 280 nm from the RP-HPLC of human (panel A) and rabbit 
(panel B) platelet lysates (10” platelet equivalent) upon addition of 
synthetic LT& free acid, as described in Experimental Procedures. 
Peaks are labeled as follows: a: LTC,; b PGBP (HPLC internal stan- 
dard) ; c: A6-trunsLTB4 isomers; d: 5,tXiHETE isomers. 
The study of LTC, formation in rabbit leukocyte- 
platelet coincubations showed that rabbit platelets, un- 
like human platelets, were not able to process PMNL 
derived LTA, into the potent inflammatory mediator 
LTC,. Intact rabbit platelets were not able to convert 
synthetic LTA, free acid into detectable amounts of 
LTC4, suggesting that rabbit platelets do not have the 
specific LTC,-synthase enzyme. In order to test whether 
this effect was due to the absence of a potential LTA4 
carrier, we also tested human and rabbit platelet lysates, 
and still no significant metabolism was observed in rab- 
bit preparations. 
Glutathione Stransferase activity showed substantial 
variability in platelet lysates and, although it appeared 
to be lower in rabbit platelets than that observed in hu- 
man platelets, no statistically significant differences 
were observed. 
Recent studies in complex organ systems showed that 
perfusion of PMNL in isolated rabbit lung or heart re- 
sulted in production of significantly increased amounts 
of cysteinyl leukotrienes only when PMNL were acti- 
vated during the perfusion process (7-10). This in- 
crease was accompanied by significant functional and 
morphological modifications, suggesting that transcel- 
Sala et al. Rabbit platelets and LTCl transcellular biosynthesis 631 
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lular biosynthesis of cysteinyl leukotrienes might indeed 
be of physiopathological relevance when tight cell-cell 
interactions occur, such as during adhesion and diape- 
desis of PMNL through the microvascular eridothcliuni 
of a functioning organ system. In agreement with this 
hypothesis, a specific leukotriene synthesis inhibitor 
(LSI), BAY X1005, was able to significantly improve SLIT- 
vival after permanent ligature of the left descending 
coronary artery in the rabbit (1 0). The data in the pres- 
ent study clearly show that rabbit platelets, unable to 
synthesize LTC4 from LT&, cannot play an important 
role in the biosynthesis of cys-I,T that underlies the car- 
diac damage and the related mortality after coronary 
ligature. Vascular endothelial cells seem to be the pref- 
erential “acceptor cells” in the mechanisms of transcel- 
M a r  biosynthesis of cys-LT in the rabbit, in agreement 
with the in vitro observations using both human and 
rabbit PMNL to perfuse isolated rabbit heart or  lung. 
Platelet-leukocyte interactions involving the produc- 
tion of lipoxygenase products are of potential signifi- 
cance in humans for the inflammatory process, hemo- 
stasis, and thrombosis, particularly in light 01 the fact 
that they are aspirin-insensitive interactions (2.5-27), 
and therefore special care must be taken using the rab- 
bit as an experimental model. 
Large amounts of the double oxygenation product 
5,12-diHETE were observed in leukoycte-platelet coin- 
cubations, in agreement with published data (16) and 
according to the sequential action of leukocyte 5-LO 
and platelet 12-LO on arachidonic acid, with transfer of 
either 5-HETE or  1PHETE from one cell to the other. 
In purified rabbit PMNL preparations, LTB4 produc- 
tion was about 2-fold higher than in mixed leukocyte 
preparations, where PMNL might represent up to 70% 
of the total leukocytes. Therefore, the observed increase 
was not merely due to the increased number of PMNL, 
and suggested that the autocrine effect of LTB, and 
platelet-activating factor (PAF) on neutrophils 54,O ob- 
served in purified PMNL preparations (28) may be sig- 
nificantly blunted in mixed leukocyte preparations. 
A significant increase in LTB4 production was ob- 
served upon addition of platelets to mixed leukocyte 
preparations, but not to purified rabbit PMNL prepara- 
tions. These results are in agreement with those of 
Maclouf e t  al. (29) and Antoine et al. (SO), obtained 
using very similar experimental conditions. 1 2-Hydro- 
peroxyeicosatetraenoic acid (l‘L-HpETE), derived from 
platelet arachidonic acid oxidative nletdboliSm, has 
been shown to activate the human blood leukocyte 5- 
lipoxygenase (29), and therefore is a likely candidate to 
account for the enhanced LTB4 production in platelet- 
mixed leukocyte coincubations. The lack of  further en- 
hancement of I,TB4 production in purified PMNL- 
platelet coincubations seems to suggest -that the auto- 
crine activation 0f5-1~0 by LTKI is t io t  additive with that 
I n  conclusion we show that rabbit PMNL, arc able t o  
export intact LT&, while rabbit platelets, unlike human 
or  bovine platelets, are not able to metabolize LTA, into 
LTC, to  a significant extent. The results of the present 
study provide important information for the proper de- 
sign and/or  interpretation of research involving the  
rabbit as an experimental mode1. l  
of 12-HpETE. 
iLf/inu>rri{)t Ieyei71ed 6 iblurth 1996, in rucitrrl /of771 21 OrtO/Jf‘l I W h ,  i i l l d  
in r w u c i ~ d  furm I O , & n u n ~  1997. 
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